{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:08:13Z","timestamp":1790208493929,"version":"4.1.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2006,9,15]],"date-time":"2006-09-15T00:00:00Z","timestamp":1158278400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.0020092","type":"journal-article","created":{"date-parts":[[2006,9,11]],"date-time":"2006-09-11T15:39:08Z","timestamp":1157989148000},"page":"e92","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":160,"title":["Doxycycline Reduces Plasma VEGF-C\/sVEGFR-3 and Improves Pathology in Lymphatic Filariasis"],"prefix":"10.1371","volume":"2","author":[{"given":"Alexander Yaw","family":"Debrah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Mand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeboah","family":"Marfo-Debrekyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Batsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Pfarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Larbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohene","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2006,9,15]]},"reference":[{"key":"ppat-0020092-b001","unstructured":"World Health Organization 2005 WHO annual report on lymphatic filariasis 2004 Available: http:\/\/www.filariasis.org. Accessed 12 October 2005."},{"key":"ppat-0020092-b002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-4758(00)01647-1","article-title":"Elimination of lymphatic filariasis as a public health problem.","volume":"16","year":"2000","journal-title":"Parasitol Today"},{"key":"ppat-0020092-b003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0035-9203(97)90405-3","article-title":"Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo.","volume":"91","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b004","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMoa021309","article-title":"Mass treatment to eliminate filariasis in Papua New Guinea.","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"ppat-0020092-b005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.trstmh.2004.01.004","article-title":"Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: Follow-up at 10 years after treatment.","volume":"98","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0035-9203(96)90534-9","article-title":"Mass DEC chemotherapy for control of bancroftian filariasis: Comparative efficacy of four strategies two years after start of treatment.","volume":"90","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b007","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0035-9203(01)90031-8","article-title":"A randomized, double-blind, placebo-controlled study with diethylcarbamazine for the treatment of hydrocoele in an area of Tanzania endemic for lymphatic filariasis.","volume":"95","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b008","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1179\/000349804225021451","article-title":"The efficacies of affected-limb care with penicillin diethylcarbamazine, the combination of both drugs or antibiotic ointment, in the prevention of acute adenolymphangitis during bancroftian filariasis.","volume":"98","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"ppat-0020092-b009","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4269\/ajtmh.1995.52.258","article-title":"Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis.","volume":"52","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ppat-0020092-b010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-3156.2005.01442.x","article-title":"A randomized clinical trial to compare the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lymphedema.","volume":"10","year":"2005","journal-title":"Trop Med Int Health"},{"key":"ppat-0020092-b011","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1586\/14787210.1.4.571","article-title":"Chemotherapy for lymphatic filariasis: Progress but not perfection.","volume":"1","year":"2003","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ppat-0020092-b012","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1475-2883-2-5","article-title":"Some observations on the effect of Daflon (micronized purified flavonoid fraction of Rutaceae aurantiae) in bancroftian filarial lymphedema.","volume":"2","year":"2003","journal-title":"Filaria J"},{"issue":"(Suppl)","key":"ppat-0020092-b013","first-page":"12","article-title":"LF disease\u2014Clinical management. In: Towards a strategic plan for research to support the global program to eliminate lymphatic filariasis. Summary of immediate needs and opportunities for research on lymphatic filariasis. Philadelphia, Pennsylvania, USA, December 9\u201310, 2003.","volume":"71","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ppat-0020092-b014","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0169-4758(99)01533-1","article-title":"Wolbachia bacteria of filarial nematodes.","volume":"15","year":"1999","journal-title":"Parasitol Today"},{"key":"ppat-0020092-b015","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1126\/science.1068732","article-title":"The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness.","volume":"295","year":"2002","journal-title":"Science"},{"key":"ppat-0020092-b016","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1749-6632.2003.tb07409.x","article-title":"Wolbachia in the inflammatory pathogenesis of human filariasis.","volume":"990","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"ppat-0020092-b017","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/09680519030090060101","article-title":"Immunopathogenesis of Onchocerca volvulus keratitis (river blindness): A novel role for TLR4 and endosymbiotic Wolbachia bacteria.","volume":"9","year":"2003","journal-title":"J Endotoxin Res"},{"key":"ppat-0020092-b018","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4269\/ajtmh.1992.46.745","article-title":"Renal abnormalities in microfilaremic patients with Bancroftian filariasis.","volume":"46","year":"1992","journal-title":"Am J Trop Med Hyg"},{"key":"ppat-0020092-b019","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/infdis\/171.3.755","article-title":"Clinical, parasitologic, and immunologic observations of patients with hydrocele and elephantiasis in an area with endemic lymphatic filariasis.","volume":"171","year":"1995","journal-title":"J Infect Dis"},{"key":"ppat-0020092-b020","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0169-4758(00)01778-6","article-title":"Pathogenesis of lymphatic disease in bancroftian filariasis: A clinical perspective.","volume":"16","year":"2000","journal-title":"Parasitol Today"},{"key":"ppat-0020092-b021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1471-4922(03)00004-7","article-title":"Aping Jane Goodall: Insights into human lymphatic filariasis.","volume":"19","year":"2003","journal-title":"Trends Parasitol"},{"key":"ppat-0020092-b022","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.it.2004.05.003","article-title":"Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.","volume":"25","year":"2004","journal-title":"Trends Immunol"},{"key":"ppat-0020092-b023","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1532\/IJH97.04042","article-title":"Molecular mechanisms of lymphangiogenesis.","volume":"80","year":"2004","journal-title":"Int J Hematol"},{"key":"ppat-0020092-b024","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jemt.1163","article-title":"Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology.","volume":"55","year":"2001","journal-title":"Microsc Res Tech"},{"key":"ppat-0020092-b025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1067\/mjd.2002.120909","article-title":"Lymphedema: An immunologically vulnerable site for development of neoplasms.","volume":"47","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"ppat-0020092-b026","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1749-6632.2002.tb04871.x","article-title":"Insights into the molecular pathogenesis and targeted treatment of lymphedema.","volume":"979","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"ppat-0020092-b027","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0955-0674(98)80137-3","article-title":"Signaling angiogenesis and lymphangiogenesis.","volume":"10","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"ppat-0020092-b028","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).","volume":"95","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat-0020092-b029","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/emboj\/20.6.1223","article-title":"Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.","volume":"20","year":"2001","journal-title":"EMBO J"},{"key":"ppat-0020092-b030","doi-asserted-by":"crossref","first-page":"14389","DOI":"10.1073\/pnas.95.24.14389","article-title":"Vascular endothelial growth factor C induces angiogenesis in vivo.","volume":"95","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat-0020092-b031","doi-asserted-by":"crossref","first-page":"19166","DOI":"10.1074\/jbc.M100097200","article-title":"The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man.","volume":"276","year":"2001","journal-title":"J Biol Chem"},{"key":"ppat-0020092-b032","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.276.5317.1423","article-title":"Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.","volume":"276","year":"1997","journal-title":"Science"},{"key":"ppat-0020092-b033","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","article-title":"Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.","volume":"92","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat-0020092-b034","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1242\/dev.122.12.3829","article-title":"VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.","volume":"122","year":"1996","journal-title":"Development"},{"key":"ppat-0020092-b035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-3024.2001.00400.x","article-title":"Wolbachia bacteria in filarial immunity and disease.","volume":"23","year":"2001","journal-title":"Parasite Immunol"},{"key":"ppat-0020092-b036","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/84651","article-title":"Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.","volume":"7","year":"2001","journal-title":"Nat Med"},{"key":"ppat-0020092-b037","doi-asserted-by":"crossref","first-page":"8413","DOI":"10.1074\/jbc.273.14.8413","article-title":"Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C.","volume":"273","year":"1998","journal-title":"J Biol Chem"},{"key":"ppat-0020092-b038","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1084\/jem.191.8.1429","article-title":"Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria.","volume":"191","year":"2000","journal-title":"J Exp Med"},{"key":"ppat-0020092-b039","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1348-0421.1999.tb02404.x","article-title":"Proinflammatory cytokines secreted by monocytes of filarial patients.","volume":"43","year":"1999","journal-title":"Microbiol Immunol"},{"key":"ppat-0020092-b040","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1286-4579(00)01269-7","article-title":"Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and anti-inflammatory responses of human monocytes.","volume":"2","year":"2000","journal-title":"Microbes Infect"},{"key":"ppat-0020092-b041","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0065-308X(05)60004-8","article-title":"Wolbachia bacterial endosymbionts of filarial nematodes.","volume":"60","year":"2005","journal-title":"Adv Parasitol"},{"key":"ppat-0020092-b042","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(05)66591-9","article-title":"Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: A double-blind, randomised placebo-controlled trial.","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"ppat-0020092-b043","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(00)02095-X","article-title":"Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis.","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"ppat-0020092-b044","first-page":"261","article-title":"Doxycycline as a novel strategy against bancroftian filariasis\u2014Depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilariae production.","volume":"5","year":"2003","journal-title":"Med Microbiol Immunol"},{"key":"ppat-0020092-b045","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/501351","article-title":"A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.","volume":"42","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ppat-0020092-b046","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-3156.2004.01304.x","article-title":"Reliable and frequent detection of adult Wuchereria bancrofti in Ghanaian women by ultrasonography.","volume":"9","year":"2004","journal-title":"Trop Med Int Health"},{"key":"ppat-0020092-b047","unstructured":"DreyerGAddissDDreyerPNoroesJ 2002 Basic lymphedema management: Treatment and prevention of problems associated with lymphatic filariasis Hollis (New Hampshire) Hollis Publishing 112 p."},{"issue":"(Suppl)","key":"ppat-0020092-b048","first-page":"7","article-title":"Essential tools\u2014Drugs and clinical drug trials. In: Towards a strategic plan for research to support the global program to eliminate lymphatic filariasis. Summary of immediate needs and opportunities for research on lymphatic filariasis. Philadelphia, Pennsylvania, USA, December 9\u201310, 2003.","volume":"71","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ppat-0020092-b049","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.pt.2003.09.004","article-title":"Mass drug treatment for lymphatic filariasis and onchocerciasis.","volume":"19","year":"2003","journal-title":"Trends Parasitol"},{"key":"ppat-0020092-b050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2883-2-2","article-title":"Final report of the Conference on the Eradicability of Onchocerciasis.","volume":"2","year":"2003","journal-title":"Filaria J"},{"key":"ppat-0020092-b051","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1286-4579(03)00026-1","article-title":"Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms.","volume":"5","year":"2003","journal-title":"Microbes Infect"},{"key":"ppat-0020092-b052","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(00)04581-5","article-title":"Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment.","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"ppat-0020092-b053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2883-5-1","article-title":"Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin.","volume":"5","year":"2006","journal-title":"Filaria J"},{"issue":"(Suppl)","key":"ppat-0020092-b054","first-page":"2","article-title":"Essential tools\u2014Diagnostics. In: Towards a strategic plan for research to support the global program to eliminate lymphatic filariasis. Summary of immediate needs and opportunities for research on lymphatic filariasis. Philadelphia, Pennsylvania, USA, December 9\u201310, 2003.","volume":"71","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ppat-0020092-b055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0035-9203(00)90278-5","article-title":"A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.","volume":"94","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b056","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.trstmh.2003.12.005","article-title":"The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.","volume":"98","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b057","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-3156.2005.01458.x","article-title":"Albendazole for the control and elimination of lymphatic filariasis: systematic review.","volume":"10","year":"2005","journal-title":"Trop Med Int Health"},{"key":"ppat-0020092-b058","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4269\/ajtmh.1991.44.691","article-title":"Evaluation of a monoclonal-antibody based antigen assay for diagnosis of Wuchereria bancrofti infection in Egypt.","volume":"44","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"ppat-0020092-b059","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/j.1460-2075.1996.tb00521.x","article-title":"A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.","volume":"15","year":"1996","journal-title":"EMBO J"},{"key":"ppat-0020092-b060","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.93.5.1988","article-title":"Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.","volume":"93","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ppat-0020092-b061","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/84643","article-title":"Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.","volume":"7","year":"2001","journal-title":"Nat Med"},{"key":"ppat-0020092-b062","first-page":"1599","article-title":"Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.","volume":"58","year":"1998","journal-title":"Cancer Res"},{"key":"ppat-0020092-b063","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","article-title":"Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.","volume":"20","year":"2001","journal-title":"EMBO J"},{"key":"ppat-0020092-b064","first-page":"931","article-title":"Angiogenesis in breast cancer: how should we measure this? (Review).","volume":"13","year":"2005","journal-title":"Oncol Rep"},{"key":"ppat-0020092-b065","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/sj.bjc.6601145","article-title":"Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy.","volume":"89","year":"2003","journal-title":"Br J Cancer"},{"key":"ppat-0020092-b066","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/cncr.20819","article-title":"Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.","volume":"103","year":"2005","journal-title":"Cancer"},{"key":"ppat-0020092-b067","first-page":"125","article-title":"Fine structure of intrascrotal lymphatic vessels infected by Wuchereria bancrofti adult worms.","volume":"33","year":"2001","journal-title":"J Submicrosc Cytol Pathol"},{"key":"ppat-0020092-b068","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0035-9203(96)90478-2","article-title":"Occurrence of living adult Wuchereria bancrofti in the scrotal area of men with microfilaremia.","volume":"90","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b069","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/00034983.1998.11813316","article-title":"Prevention of acute adenolymphangitis in brugian filariasis: Comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb.","volume":"92","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"ppat-0020092-b070","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00034983.1999.11813433","article-title":"A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphedema caused by brugian filariasis.","volume":"93","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"key":"ppat-0020092-b071","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0035-9203(95)90666-5","article-title":"Episodic adenolymphagitis and lymphedema in patients with bancroftian filariasis.","volume":"89","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ppat-0020092-b072","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00034983.1996.11813024","article-title":"The economic burden of lymphatic filariasis in northern Ghana.","volume":"90","year":"1996","journal-title":"Ann Trop Med Parasitol"},{"key":"ppat-0020092-b073","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00034983.2000.11813550","article-title":"The impact of lymphatic filariasis on labour inputs in southern India: Results of a multi-site study.","volume":"94","year":"2000","journal-title":"Ann Trop Med Parasitol"},{"key":"ppat-0020092-b074","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0891-5520(20)30546-8","article-title":"Filarial infections.","volume":"7","year":"1993","journal-title":"Infect Dis Clin North Am"},{"key":"ppat-0020092-b075","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(94)91547-4","article-title":"\u201cFilarial\u201d adenolymphangitis without filarial infection.","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"ppat-0020092-b076","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00034983.1993.11812763","article-title":"Reduction of filaritic lymphedema and elephantiasis by 5,6 benzo-alpha-pyrone (coumarin), and the effects of diethylcarbamazine (DEC).","volume":"87","year":"1993","journal-title":"Ann Trop Med Parasitol"},{"key":"ppat-0020092-b077","first-page":"2","article-title":"Coumarin (Lodema).","volume":"10","author":"World Health Organization","year":"1996","journal-title":"WHO Pharm Newsl"},{"key":"ppat-0020092-b078","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-3156.1998.00170.x","article-title":"Quantitative assessment of circulating antigens in human lymphatic filariasis: A field evaluation of monoclonal antibody-based ELISA using blood collected on filter strips.","volume":"3","year":"1998","journal-title":"Trop Med Int Health"},{"key":"ppat-0020092-b079","first-page":"32","article-title":"Chronic infection of cats with Brugia malayi and streptococcus.","volume":"11","year":"1980","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ppat-0020092-b080","first-page":"40","article-title":"Skin changes in filarial and non-filarial lymphedema of the lower extremities.","volume":"44","year":"1993","journal-title":"Trop Med Parasitol"},{"key":"ppat-0020092-b081","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-3024.2005.00732.x","article-title":"Soluble cellular adhesion molecules, selectins, VEGF and endothelin-1 in patients with Wuchereria bancrofti infection and association with clinical status.","volume":"27","year":"2005","journal-title":"Parasite Immunol"},{"key":"ppat-0020092-b082","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/303019","article-title":"Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.","volume":"67","year":"2000","journal-title":"Am J Hum Genet"},{"key":"ppat-0020092-b083","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2883-2-3","article-title":"Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis.","volume":"2","year":"2003","journal-title":"Filaria J"},{"key":"ppat-0020092-b084","first-page":"564","article-title":"Arrangement and fine structure of lymphatic vessels in the human spermatic cord.","volume":"6","year":"1980","journal-title":"Adrologia"},{"key":"ppat-0020092-b085","doi-asserted-by":"crossref","unstructured":"KumaraswamiV 2000 The clinical manifestations of lymphatic filariasis. In: NutmanTB Tropical medicine in science and practice. Volume 1 London Imperial College Press pp. 103 125","DOI":"10.1142\/9781848160866_0005"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.0020092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T20:34:45Z","timestamp":1736541285000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.0020092"}},"subtitle":[],"editor":[{"given":"Kasturi","family":"Haldar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,9,15]]},"references-count":85,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2006,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.0020092","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,15]]}}}